Compass Therapeutics CEO Thomas Schuetz's 2023 pay jumps 130% to $4.9M
Compass Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 29, 2024
Compass Therapeutics reported fiscal year 2023 executive compensation information on April 29, 2024.
In 2023, two executives at Compass Therapeutics received on average a compensation package of $4.5M, a 133% increase compared to previous year.
Average pay of disclosed executives at Compass Therapeutics
Thomas J. Schuetz, Chief Executive Officer, received $4.9M in total, which increased by 130% compared to 2022. 43% of Schuetz's compensation, or $2.1M, was in option awards. Schuetz also received $244K in bonus, $575K in salary, $2M in stock awards, as well as $17K in other compensation.
Vered Bisker-Leib, Chief Executive Officer, received a compensation package of $4.1M, which increased by 136% compared to previous year. 44% of the compensation package, or $1.8M, was in option awards.
Related executives
You may also like
Source: SEC filing on April 29, 2024.